Cultivate, published by DLA Piper, focuses on legal developments and regulatory issues related to cannabis, hemp, and cannabidiol (CBD) products. The blog covers topics such as federal drug scheduling and its impact on the cannabis industry, legislative efforts to regulate hemp-derived CBD as dietary supplements, FDA regulatory positions on CBD and related products, and federal research initiatives on medical marijuana and CBD. It also addresses tax and banking implications for cannabis businesses, as well as the evolving landscape of federal agency oversight concerning hemp and cannabis products.